Nearly 90% of executives leading medical-technology companies see emerging technologies as a top challenge. And they’re struggling to apply these advances not only to their product and service lines but also to their own business operations.

AI, the group wrote, could "usurp the EHR as the most disappointing application of technology within medicine”

AI holds the promise of improving gerontology by making it more predictive, personalized, preventive and participatory. However, to get there, an equal number of pronounced risks must be negotiated.  

Patient-facing healthcare workers are neither softened nor hardened in their attitudes toward clinical decision support powered by AI when it’s instead called “AHI,” for augmented human intelligence.

An AI system trained to supply clinical decision support in the U.S. has proven adaptable for physicians treating patients with lung cancer on the other side of the globe.

The approval means Abiomed can stream patient data from its Impella heart pumps to remote monitoring platforms installed at more than 200 hospitals.

The vast majority of patients with suspected melanoma—94%—would welcome the use of AI as an augmenter of their dermatologist’s diagnostic skills. And more than 40% would trust their diagnosis to a standalone AI system.  

The solution, Caption AI, was designed to help users “without lengthy specialized training” capture high-quality images.